Catalyst Biosciences Inc Stock
Catalyst Biosciences Inc Stock
Currently there is a rather positive sentiment for Catalyst Biosciences Inc with 4 Buy predictions and 0 Sell predictions.
With a target price of 21 € there is potential for a 3942.35% increase which would mean more than doubling the current price of 0.52 € for Catalyst Biosciences Inc.
Our community identified positive and negative aspects for Catalyst Biosciences Inc stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Catalyst Biosciences Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Catalyst Biosciences Inc in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Catalyst Biosciences Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Catalyst Biosciences Inc | - | - | - | - | - | - | - |
| Pacira Pharmaceuticals | 2.630% | 3.540% | 5.405% | 25.134% | 8.333% | -28.221% | -52.439% |
| Supernus Pharmaceuticals | -2.960% | -4.369% | -2.956% | 35.862% | -8.372% | 42.754% | 79.091% |
| Collegium Pharmaceutical Inc | -0.640% | 0.645% | -1.266% | 18.182% | -24.638% | 57.576% | 51.456% |
Comments
Crescent Biopharma (CBIO) had its price target lowered by HC Wainwright from $25.00 to $22.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CBIO provided by MarketBeat
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Guggenheim. They set a "buy" rating and a $35.00 price target on the stock.
Show more
Ratings data for CBIO provided by MarketBeat
Crescent Biopharma (NASDAQ:CBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Show more
Ratings data for CBIO provided by MarketBeat